180 Life Sciences (ATNF) has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the recent appointment of Mr. Stephen Shoemaker as an independent director of the Company and as a member of the Company’s audit committee. With this appointment, 180 is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATNF:
- 180 Life Sciences Expands Board with Stephen Shoemaker
- 180 Life Sciences appoints Stephen Shoemaker to board of directors
- 180 Life Sciences files to sell 1.9M shares of common stock for holders
- 180 Life Sciences Expands into Online Gaming Sector
- 180 Life Sciences appoints Vaclav Vincalek as Senior Technology Consultant